Skip to main content
Equibles
KMTS logo

KMTS · Kestra Medical Technologies, Ltd. · Webcasts, Transcripts & Audio

Track KMTS — free

Use KMTS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KMTS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$28.34 +0.91 (+3.32%) At close · Oct 5
Russell 2000 member Rebalance outlook locked
Market Cap
$1.62B
Shares
59.56M
Volume · Oct 5 293.64K Avg daily vol (3M) 368.22K

Kestra Medical Technologies, Ltd. Webcasts

Earnings calls, investor updates, investor days and conferences for Kestra Medical Technologies, Ltd. (KMTS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $15.09M −$21.51M '25 Q3 25-04-14 · $17.23M −$52.05M '25 Q4 25-07-15 ▲51.5% $19.37M −$25.83M '26 Q1 25-09-11 ▲53.4% $22.57M −$32.78M '26 Q2 25-12-11 ▲62.7% $24.55M −$34.17M '26 Q3 26-03-17 ▲66.2% $28.64M −$38.84M '26 Q4 26-07-14 LATEST ▲59.9% $30.97M −$44.09M '27 Q1 26-09-14
Earnings call
FY27 · Q1
2026-09-14
Kestra Medical Technologies, Ltd. (KMTS) Q1 2027 Earnings Call
Revenue
$30.97M
▲ 59.9% YoY
Diluted EPS
$-0.75
Gross margin
56.5%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q4
2026-07-14
Kestra Medical Technologies, Ltd. (KMTS) Q4 2026 Earnings Call Transcript
Confident tone FY27 outlook and investments Gross margin expansion Geographic and territory coverage
Revenue
$28.64M*
▲ 66.2% YoY
Gross margin
54.8%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY26 · Q3
2026-03-17
Kestra Medical Technologies, Ltd. (KMTS) Q3 2026 Earnings Call Transcript
Confident tone Revenue growth and financial performance Sales force and territory expansion Product innovation and Assure system
Revenue
$24.55M
▲ 62.7% YoY
Diluted EPS
$-0.61
Gross margin
52.6%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2025-12-11
Kestra Medical Technologies, Ltd. (KMTS) Q2 2026 Earnings Call Transcript
Confident tone Patient Story / Outcomes Financial Performance ACE PAS Clinical Study
Revenue
$22.57M
▲ 53.4% YoY
Diluted EPS
$-0.64
Gross margin
50.6%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2025-09-11
Kestra Medical Technologies, Ltd. (KMTS) Q1 2026 Earnings Call Transcript
Confident tone Revenue growth and prescriptions Patient impact / mission Revenue cycle management and payer coverage
Revenue
$19.37M
▲ 51.5% YoY
Diluted EPS
$-0.50
Gross margin
45.7%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-07-15
Kestra Medical Technologies, Ltd. (KMTS) Q4 2025 Earnings Call
Revenue
$17.23M*
Gross margin
44.3%
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-04-14
Kestra Medical Technologies, Ltd. (KMTS) Q3 2025 Earnings Call
Revenue
$15.09M
Diluted EPS
$-1.25
Gross margin
43.4%
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–7 of 7 webcasts
Key facts CIK 1877184 CUSIP G52441105 13F (30d) 3 filings 3 filers Visit website Investor relations